This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Edwards, L J Articles by Constantinescu, C S Search for Related Content PubMed PubMed Citation Articles by Edwards, L J Articles by Constantinescu, C S Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Asthma Multiple Sclerosis Social Bookmarking                         What's this?

A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic

Division of Clinical Neurology, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK

C S Constantinescu

Division of Clinical Neurology, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK, cris.constantinescu{at}nottingham.ac.uk

The cause of multiple sclerosis (MS) remains unknown. It is largely regarded as being an inflammatory autoimmune disease and has been reported in association with other inflammatory/autoimmune diseases. We performed a prospective study in 658 consecutive patients diagnosed with MS attending our outpatient MS management clinic between June 2002 and June 2003. Prevalence of associated conditions in these patients was calculated and compared with values from population studies using chi-square tests, odds ratios and confidence intervals. The MS population had significantly increased rates of asthma, inflammatory bowel disease, type I diabetes mellitus, pernicious anaemia, autoimmune thyroid disease, uveitis, seronegative spondyloarthropathies, bipolar disorder and melanoma compared to the general population. Both T helper type 1 (Th1)-mediated and T helper type 2 (Th2)-mediated diseases were significantly increased compared to the general population. There were also interesting associations seen with polyglandular autoimmune syndrome and rare single case associations.

MS is associated with several other conditions. This work does not give evidence for the hypothesis that MS and atopy, reflecting Th1 and Th2 polarization, respectively, are mutually exclusive. Further work, ideally with a matched control population, is indicated.

Key Words: associated conditions • asthma • atopy • autoimmune disease • multiple sclerosis • Th1/Th2

Multiple Sclerosis, Vol. 10, No. 5, 575-581 (2004)
DOI: 10.1191/1352458504ms1087oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R Pedotti, M Farinotti, C Falcone, L Borgonovo, P Confalonieri, A Campanella, R Mantegazza, E Pastorello, and G Filippini Allergy and multiple sclerosis: a population-based case-control study Multiple Sclerosis, August 1, 2009; 15(8): 899 - 906. [Abstract] [PDF]

				R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated Multiple Sclerosis, March 1, 2009; 15(3): 385 - 392. [Abstract] [PDF]

				R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer Comorbidity, socioeconomic status and multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1091 - 1098. [Abstract] [PDF]

				L. Edwards, J. Atherton, A. Zaitoun, and C. Constantinescu Letter to the Editor: A case of dysphagia with clinically isolated syndrome Multiple Sclerosis, June 1, 2008; 14(5): 716 - 717. [PDF]

				J. Vilisaar, S. Harikrishnan, M. Suri, and C. Constantinescu Ehlers--Danlos syndrome and multiple sclerosis: a possible association Multiple Sclerosis, May 1, 2008; 14(4): 567 - 570. [Abstract] [PDF]

				C. Lebrun, M. Debouverie, P. Vermersch, P. Clavelou, L. Rumbach, J. de Seze, S. Wiertlevski, G. Defer, O. Gout, F. Berthier, et al. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis Multiple Sclerosis, April 1, 2008; 14(3): 399 - 405. [Abstract] [PDF]

				J. N. Kline Eat Dirt: CpG DNA and Immunomodulation of Asthma Proceedings of the ATS, July 1, 2007; 4(3): 283 - 288. [Abstract] [Full Text] [PDF]

				K. Kitagaki, T. R. Businga, D. Racila, D. E. Elliott, J. V. Weinstock, and J. N. Kline Intestinal Helminths Protect in a Murine Model of Asthma J. Immunol., August 1, 2006; 177(3): 1628 - 1635. [Abstract] [Full Text] [PDF]

				J M van Noort, R Verbeek, J F Meilof, C H Polman, and S Amor Autoantibodies against alpha B-crystallin, a candidate autoantigen in multiple sclerosis, are part of a normal human immune repertoire Multiple Sclerosis, June 1, 2006; 12(3): 287 - 293. [Abstract] [PDF]